...
首页> 外文期刊>Cell death & disease. >Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
【24h】

Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease

机译:RIP3的消融免受实验帕金森病中的多巴胺能神经变性的保护

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Parkinson's disease (PD) is driven by dopaminergic neurodegeneration in the substantia nigra pars compacta (SN) and striatum. Although apoptosis is considered the main neurodegenerative mechanism, other cell death pathways may be involved. In this regard, necroptosis is a regulated form of cell death dependent on receptor interacting protein 3 (RIP3), a protein also implicated in apoptosis and inflammation independently of its pro-necroptotic activity. Here, we explored the role of RIP3 genetic deletion in in vivo and in vitro PD models. Firstly, wild-type (Wt) and RIP3 knockout (RIP3ko) mice were injected intraperitoneally with MPTP (40?mg/kg, i.p.), and sacrificed after either 6 or 30 days. RIP3ko protected from dopaminergic neurodegeneration in the SN of MPTP-injected mice, but this effect was independent of necroptosis. In keeping with this, necrostatin-1s (10?mg/kg/day, i.p.) did not afford full neuroprotection. Moreover, MPTP led to DNA fragmentation, caspase-3 activation, lipid peroxidation and BAX expression in Wt mice, in the absence of caspase-8 cleavage, suggesting intrinsic apoptosis. This was mimicked in primary cortical neuronal cultures exposed to the active MPTP metabolite. RIP3 deficiency in cultured cells and in mouse brain abrogated all phenotypes. Curiously, astrogliosis was increased in the striatum of MPTP-injected Wt mice and further exacerbated in RIP3ko mice. This was accompanied by absence of microgliosis and reposition of glial cell line-derived neurotrophic factor (GDNF) levels in the striata of MPTP-injected RIP3ko mice when compared to MPTP-injected Wt mice, which in turn showed a massive GDNF decrease. RIP3ko primary mixed glial cultures also presented decreased expression of inflammation-related genes upon inflammatory stimulation. These findings hint at possible undescribed non-necroptotic roles for RIP3 in inflammation and MPTP-driven cell death, which can contribute to PD progression.
机译:帕金森病(PD)是由多巴胺能神经变性的动力驱动的,在IndicaIa nigra parscompacta(Sn)和纹状体中。虽然细胞凋亡被认为是主要的神经退行性机制,但可能涉及其他细胞死亡途径。在这方面,Necroptis是一种依赖于受体相互作用蛋白3(RIP3)的细胞死亡的调节形式的细胞死亡形式,该蛋白质也与其亲毒性的活性相同的蛋白质涉及细胞凋亡和炎症。在这里,我们探讨了RIP3遗传缺失在体内和体外PD模型中的作用。首先,用MPTP(40×mg / kg,I.p.)腹膜内注射野生型(WT)和RIP3敲除(RIP3KO)小鼠,并在6或30天后处死。 RIP3KO在MPTP注射的小鼠SN中保护多巴胺能神经变性,但这种效果与虐疮无关。在保持这种情况下,NecroStatin-1S(10?Mg / kg /天,I.P.)没有得到全神经保护作用。此外,在没有Caspase-8切割的情况下,MPTP导致WT小鼠的DNA碎片,Caspase-3活化,脂质过氧化和Bax表达,表明内在的细胞凋亡。这在暴露于活性MPTP代谢物的原发性皮质神经元培养物中模仿。 RIP3缺乏培养细胞和小鼠脑中的缺乏所有表型。好奇地,在MPTP注射的WT小鼠的纹状体中增加了星形曲线,并在RIP3KO小鼠中进一步加剧。与MPTP注入的WT小鼠相比,这伴随着微细胞分子和重新定位MPTP注射的RIP3KO小鼠的斜面中的椎智细胞系衍生的神经营养因子(GDNF)水平,这反过来又显示出大量的GDNF降低。 RIP3KO初级混合胶质培养物还表现出炎症刺激后炎症相关基因的表达降低。这些调查结果暗示炎症和MPTP驱动的细胞死亡中的RIP3可能是未描述的非肮脏作用,这可能有助于PD进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号